Abstract：
In Late January 2023, the National Institute of Biomedical Imaging and Bioengineering (NIBIB) launched a new center designed to accelerate biomedical discovery and therapeutics, in part by pulling together expert, multidisciplinary teams from throughout the National Institutes of Health (NIH) to quickly respond when national or global health crises strike. The inaugural director of this Center for BME Technology Acceleration, or BETA Center, is biomedical engineer Manu Platt, Ph.D., (Figure 1) who is also taking on the role of NIBIB associate director for scientific diversity, equity, and inclusion. Platt previously held appointments as professor, Wallace H. Coulter distinguished faculty fellow, and diversity director of the Center on Emergent Behaviors of Integrated Cellular Systems and Cellular Manufacturing and Technologies at the Georgia Institute of Technology and Emory University.
摘要：
2023年1月下旬，美国国家生物医学成像和生物工程研究所（NIBIB）启动了一个旨在加速生物医学发现和治疗的新中心。部分是通过召集专家，来自美国国立卫生研究院（NIH）的多学科团队，在国家或全球健康危机发生时迅速做出反应。这个BME技术加速中心的首任主任，或测试中心，是生物医学工程师ManuPlatt,博士,（图1）他还担任NIBIB科学多样性副主任，股本，和包容。Platt之前曾被任命为教授，华莱士H.库尔特杰出的教员，佐治亚理工学院和埃默里大学的集成细胞系统和细胞制造和技术的新兴行为中心的多样性主任。
